知镜 Cognispect · 医学文献与研究工作台

Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic review.

Zhong W, Li CYV, Chan AHY, Kongkaew C, Blais JE, Blais JE.
JBI evidence synthesis · 2026-06-19 · PMID 42312678

文献摘要

Objectives The objective of this study within a review was to assess the completeness of EMERGE (ESPACOMP Medication Adherence Reporting Guideline) item reporting in observational studies included in a systematic review assessing proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor medication adherence in clinical practice. Secondary objectives were to compare the completeness of reporting between studies that explicitly aimed to investigate medication adherence and those that did not, and to identify the relevance of these findings for other systematic reviews. Introduction The International Society for Medication Adherence published the EMERGE in 2018. Although EMERGE aims to improve and standardize the reporting of research on medication adherence, the extent to which the EMERGE guideline is followed is unknown. Methods This study within a review included 52 observational studies published after 2018 as full-length articles in the host systematic review. Completeness of reporting for each minimum and additional EMERGE item was categorized as completely reported, incompletely reported, not reported, or not applicable. Studies were grouped according to whether their primary aim was to investigate medication adherence (Group 1) or not (Group 2). The completeness of reporting each EMERGE item was compared between groups using Fisher's exact test. Additionally, the proportion of completely reported items was compared between the groups using the t-test and Mann-Whitney U test. Results Among the 4 minimum EMERGE items, item 1d (Describe results for the medication adherence phase) was the most often completely reported (80.8%), while item 1b (Provide a precise operation definition) was the least completely reported (38.5%). Among the additional 17 EMERGE items, item 5b (State whether medication adherence was an eligibility criterion) was completely reported in 98.1% of studies, whereas item 5c (Describe routine care related to the management of medication adherence) was the least frequently reported. Twenty (38.5%) studies were categorized into Group 1 and 32 (61.5%) into Group 2. For all EMERGE items, minimum items, and additional items, the mean proportion of completely reported items in Group 1 was higher than that in Group 2 (P Conclusion Our findings suggest limited application of EMERGE among authors and journals publishing observational studies on PCSK9 inhibitor medication adherence. Strengthening the visibility and application of EMERGE may enhance the consistency of methodological reporting in future studies of medication adherence. Review registration SWAR Store https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/SWARFileStore/SWAR50%20Joseph%20Edgar%20Blais%20(2024%20AUG%2001%201402).pdf (SWAR50).

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。